Canadian Consensus Recommendations on the Management of <i>MET</i>-Altered NSCLC

Canadian Consensus Recommendations on the Management of <i>MET</i>-Altered NSCLC

In Canada, the therapeutic management of patients with advanced non-small cell lung cancer (NSCLC) with rare actionable mutations differs between provinces, territories, and individual centres based on access to molecular testing and funded treatments. These variations, together with the emergence o...

Full description

Bibliographic Details
Main Authors: Parneet K. Cheema, Shantanu O. Banerji, Normand Blais, Quincy S.-C. Chu, Patrice Desmeules, Rosalyn A. Juergens, Natasha B. Leighl, Brandon S. Sheffield, Paul F. Wheatley-Price, Barbara L. Melosky
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Current Oncology
Subjects:
non-small cell lung cancer
<i>MET</i> exon 14 skipping mutations
<i>MET</i> amplification
<i>MET</i> inhibitors
EGFR resistance
Online Access:https://www.mdpi.com/1718-7729/28/6/386

Internet

https://www.mdpi.com/1718-7729/28/6/386

Similar Items